We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+11.92%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$191M
AUM Growth
-$59.3M
Cap. Flow
-$76.2M
Cap. Flow %
-39.78%
Top 10 Hldgs %
5.8%
Holding
489
New
53
Increased
164
Reduced
226
Closed
46

Top Buys

Rank Stock Value
1
DHI icon
D.R. Horton
DHI
+$888K
2
LEN icon
Lennar Class A
LEN
+$880K
3
MCHP icon
Microchip Technology
MCHP
+$860K
4
AME icon
Ametek
AME
+$859K
5
HD icon
Home Depot
HD
+$853K

Sector Composition

Rank Sector Weight
1 Healthcare 26.88%
2 Financials 12.6%
3 Technology 10.15%
4 Materials 9.55%
5 Real Estate 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNA icon
301
Moderna
MRNA
$21.8B
$260K 0.14%
1,448
-492
-25% -$80.4K
ICPT
302
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$251K 0.13%
+20,251
New +$287K
BLUE
303
DELISTED
bluebird bio
BLUE
$250K 0.13%
+1,807
New +$255K
NKTR icon
304
Nektar Therapeutics
NKTR
$2.33B
$250K 0.13%
7,361
+2,560
+53% +$124K
SAR icon
305
Saratoga Investment
SAR
$311M
$249K 0.13%
9,775
-6,435
-40% -$154K
MAIN icon
306
Main Street Capital
MAIN
$5.12B
$246K 0.13%
6,658
-251
-4% -$9.17K
BNTX icon
307
BioNTech
BNTX
$23.4B
$244K 0.13%
1,626
-121
-7% -$18.6K
BBIO icon
308
BridgeBio Pharma
BBIO
$16.6B
$241K 0.13%
31,681
-4,494
-12% -$43K
FDUS icon
309
Fidus Investment
FDUS
$766M
$240K 0.13%
12,633
-4,500
-26% -$85.5K
TSVT
310
DELISTED
2seventy bio
TSVT
$230K 0.12%
+24,598
New +$347K
GAIN icon
311
Gladstone Investment Corp
GAIN
$651M
$222K 0.12%
17,227
-2,854
-14% -$37.6K
AQN icon
312
Algonquin Power & Utilities
AQN
$4.71B
$220K 0.11%
33,698
-81,494
-71% -$727K
ALT icon
313
Altimmune
ALT
$568M
$214K 0.11%
+12,993
New +$146K
OXSQ icon
314
Oxford Square Capital
OXSQ
$147M
$207K 0.11%
66,405
+1,360
+2% +$4.15K
BCIC
315
BCP Investment Corp
BCIC
$87.6M
$201K 0.1%
8,723
-2,123
-20% -$45.4K
OFS icon
316
OFS Capital
OFS
$45.8M
$193K 0.1%
18,885
-3,330
-15% -$32.6K
ILPT
317
Industrial Logistics Properties Trust
ILPT
$597M
$192K 0.1%
58,723
-54,972
-48% -$229K
NSLR
318
Neostellar Capital Corp
NSLR
$264M
$189K 0.1%
49,855
+12,038
+32% +$47.6K
MRCC
319
DELISTED
Monroe Capital Corp
MRCC
$187K 0.1%
21,868
-5,416
-20% -$44.4K
RNAM
320
DELISTED
Avidity Biosciences
RNAM
$182K 0.1%
8,215
-637
-7% -$9.5K
SMMT icon
321
Summit Therapeutics
SMMT
$9.88B
$182K 0.1%
+42,835
New +$77.9K
TGTX icon
322
TG Therapeutics
TGTX
$8.32B
$181K 0.09%
15,308
-11,827
-44% -$85.8K
AKRO
323
DELISTED
Akero Therapeutics
AKRO
$173K 0.09%
3,164
-9,817
-76% -$421K
ARWR icon
324
Arrowhead Research
ARWR
$12.3B
$173K 0.09%
4,264
+522
+14% +$17.3K
ZYME icon
325
Zymeworks
ZYME
$1.62B
$171K 0.09%
21,818
+3,838
+21% +$27K

Similar funds

Virtus ETF Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, Virtus ETF Advisers held 489 positions worth $191M, down 24% from $251M the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Virtus ETF Advisers withdrew a net $76.2M in Q4 2022, closing 46 positions and reducing 226 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $877K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 19% a quarter earlier, followed by Financials and Technology.

Against the trend, Virtus ETF Advisers opened a new position in D.R. Horton worth $987K.

  • Virtus ETF Advisers's largest Q4 2022 buy was D.R. Horton: 11,078 shares worth $987K.
  • Virtus ETF Advisers added most to Qualcomm in Q4 2022, an estimated $271K increase.
  • Virtus ETF Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $1.62M.
  • Virtus ETF Advisers fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q4 2022, selling an estimated $877K.
  • Virtus ETF Advisers's ten largest holdings make up 5.8% of its $191M portfolio in Q4 2022.
  • Virtus ETF Advisers opened 53 new positions and closed 46 in Q4 2022.
  • Virtus ETF Advisers's portfolio value fell 24% quarter-over-quarter to $191M.

Based on Virtus ETF Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.